
According to a report by esmmagazine on January 13th, Ireland will begin implementing a new retail licensing system next month aimed at combatting the illegal sale of e-cigarette products. BAT Ireland commented that this measure will play an important role in market regulation.
This policy will be implemented on February 2nd, requiring retailers to pay an annual fee of 800 euros to sell e-cigarettes and 1,000 euros to sell tobacco. Nicotine pouches are not included in this legislation.
Manager of British American Tobacco Ireland (BAT Ireland), David Melinn, stated that
We have repeatedly called for the introduction of a retail licensing system, believing it will play a crucial role in enforcing the ban on selling e-cigarettes to those under 18 and preventing the illegal sales of e-cigarette products. However, we believe the omission of regulations on nicotine pouches that do not contain tobacco is a oversight, and hope the next government will address this issue.
Stores selling e-cigarette products are required to join a registration system and undergo inspections by the Health Service Executive (HSE) in Ireland to ensure compliance with relevant regulations. Licenses are renewed annually, meaning that if a retailer's license is revoked, they will lose the eligibility to sell e-cigarettes.
Merlin added,
The majority of retailers operate responsibly, but we are concerned about some phone accessory and laptop repair shops selling e-cigarettes. We have found an increasing number of stores selling illegal e-cigarettes without the required health warnings in Ireland, which contain high levels of nicotine. We hope that this new system can crackdown on these unlawful businesses, whose actions are harming many legitimate and responsible e-cigarette retailers nationwide.
Previously, retailers selling tobacco products only had to pay a disposable fee of 50 euros, while retailers selling e-cigarettes did not require any permits. The new licensing system has been passed through statutory documents as part of the "2023 Public Health (Tobacco Products and Nicotine Inhalation Products) Act".
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.